Nobivac® KC
Nobivac KC provides immunisation against two significant causes of canine infectious respiratory disease (commonly referred to as kennel cough) and is recommended for any dogs that are regularly mixed or regularly come into contact with other dogs (e.g. kenneling, boarding, dog training etc.). Dogs at risk of this whooping cough-like syndrome benefit from vaccination against this very common and widespread threat.
Presentation
Nasal drops, off-white or cream-coloured lyophilisate and clear colourless solvent for suspension.
Active ingredients
Nobivac KC is a live freeze-dried vaccine.
Each dose (0.4 ml) of reconstituted vaccine contains:
Live Bordetella bronchiseptica bacteria strain B-C2: ≥ 108.0 and ≤ 109.7cfu1
Live canine parainfluenza virus strain Cornell: ≥ 103.0 and ≤ 105.8 TCID502
1Colony forming units
2Tissue Culture Infective Dose 50%
Target species
Dogs.
Indications for use
Nobivac KC is indicated:
- Active immunisation of dogs against Bordetella bronchiseptica and canine parainfluenza virus for periods of increased risk to reduce clinical signs induced by B. bronchiseptica and canine parainfluenza virus.
- To reduce shedding of canine parainfluenza virus.
Packaging
Cardboard or plastic boxes with:
- 5 x 1 dose of vaccine and solvent
- 25 x 1 dose of vaccine and solvent
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: September 2023